Literature DB >> 33247419

Hypothetical blood-pressure-lowering interventions and risk of stroke and dementia.

Liliana Paloma Rojas-Saunero1, Saima Hilal2,3,4, Eleanor J Murray5,6, Roger W Logan5, Mohammad Arfan Ikram2, Sonja A Swanson2,5.   

Abstract

We aimed to study the effects of hypothetical interventions on systolic blood pressure (SBP) and smoking on risk of stroke and dementia using data from 15 years of follow-up in the Rotterdam Study. We used data from 4930 individuals, aged 55-80 years, with no prior history of stroke, dementia or cognitive impairment, followed for 15 years within the Rotterdam Study, a population-based cohort. We defined the following sustained interventions on SBP: (1) maintaining SBP below 120 mmHg, (2) maintaining SBP below 140 mmHg, (3) reducing SBP by 10% if above 140 mmHg, (4) reducing SBP by 20% if above 140 mmHg, and a combined intervention of quitting smoking with each of these SBP-lowering strategies. We considered incident stroke and incident dementia diagnoses as outcomes. We applied the parametric g-formula to adjust for baseline and time-varying confounding. The observed 15-year risk for stroke was 10.7%. Compared to no specified intervention (i.e., the "natural course"), all interventions that involved reducing SBP were associated with a stroke risk reduction of about 10% (e.g., reducing SBP by 20% if above 140 mmHg risk ratio: 0.89; 95% CI 0.76, 1). Jointly intervening on SBP and smoking status further decreased the risk of stroke (e.g., risk ratio: 0.83; 95% CI 0.71, 0.94). None of the specified interventions were associated with a substantive change in dementia risk. Our study suggests that a joint intervention on SBP and smoking cessation during later life may reduce stroke risk, while the potential for reducing dementia risk were not observed.

Entities:  

Keywords:  Dementia; Hypertension; Stroke; Target trial; g-Formula

Year:  2020        PMID: 33247419     DOI: 10.1007/s10654-020-00694-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  The rising tide of dementia worldwide.

Authors:  Eric B Larson; Kenneth M Langa
Journal:  Lancet       Date:  2008-07-28       Impact factor: 79.321

2.  Healthy diet and lifestyle and risk of stroke in a prospective cohort of women.

Authors:  Alain Braillon
Journal:  Neurology       Date:  2015-06-02       Impact factor: 9.910

3.  Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

Authors:  B Neal; S MacMahon; N Chapman
Journal:  Lancet       Date:  2000-12-09       Impact factor: 79.321

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 5.  Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA.

Authors:  Ursula E Bauer; Peter A Briss; Richard A Goodman; Barbara A Bowman
Journal:  Lancet       Date:  2014-07-01       Impact factor: 79.321

6.  Primary prevention of stroke by healthy lifestyle.

Authors:  Stephanie E Chiuve; Kathryn M Rexrode; Donna Spiegelman; Giancarlo Logroscino; JoAnn E Manson; Eric B Rimm
Journal:  Circulation       Date:  2008-08-12       Impact factor: 29.690

7.  Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial.

Authors:  F Forette; M L Seux; J A Staessen; L Thijs; W H Birkenhäger; M R Babarskiene; S Babeanu; A Bossini; B Gil-Extremera; X Girerd; T Laks; E Lilov; V Moisseyev; J Tuomilehto; H Vanhanen; J Webster; Y Yodfat; R Fagard
Journal:  Lancet       Date:  1998-10-24       Impact factor: 79.321

8.  Lifestyle factors and antihypertensive treatment on the risks of ischemic and hemorrhagic stroke.

Authors:  Yurong Zhang; Jaakko Tuomilehto; Pekka Jousilahti; Yujie Wang; Riitta Antikainen; Gang Hu
Journal:  Hypertension       Date:  2012-08-06       Impact factor: 10.190

9.  Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults.

Authors:  M J Prince; A S Bird; R A Blizard; A H Mann
Journal:  BMJ       Date:  1996-03-30

Review 10.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

View more
  1 in total

1.  Turtles all the way down: do biological mechanisms for epidemiological observations always matter?

Authors:  David T P Buis; Jos van Roosmalen
Journal:  Eur J Epidemiol       Date:  2021-10-07       Impact factor: 8.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.